Constitutive Activation of Kappa Opioid Receptors at Ventral Tegmental Area

Total Page:16

File Type:pdf, Size:1020Kb

Constitutive Activation of Kappa Opioid Receptors at Ventral Tegmental Area RESEARCH ARTICLE Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress Abigail M Polter1†, Kelsey Barcomb1, Rudy W Chen1, Paige M Dingess2,3, Nicholas M Graziane1‡, Travis E Brown2,3, Julie A Kauer1* 1Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, United States; 2Neuroscience Program, University of Wyoming, Laramie, United States; 3University of Wyoming, School of Pharmacy, Laramie, United States Abstract Stressful experiences potently activate kappa opioid receptors (kORs). kORs in the ventral tegmental area regulate multiple aspects of dopaminergic and non-dopaminergic cell function. Here we show that at GABAergic synapses on rat VTA dopamine neurons, a single exposure to a brief cold-water swim stress induces prolonged activation of kORs. This is mediated *For correspondence: by activation of the receptor during the stressor followed by a persistent, ligand-independent [email protected] constitutive activation of the kOR itself. This lasting change in function is not seen at kORs at neighboring excitatory synapses, suggesting distinct time courses and mechanisms of regulation of Present address: †Department different subsets of kORs. We also provide evidence that constitutive activity of kORs governs the of Pharmacology and Physiology, The George Washington prolonged reinstatement to cocaine-seeking observed after cold water swim stress. Together, our University School of Medicine studies indicate that stress-induced constitutive activation is a novel mechanism of kOR regulation and Health Science, Washington, that plays a critical role in reinstatement of drug seeking. United States; ‡Department of DOI: 10.7554/eLife.23785.001 Neuroscience, University of Pittsburgh, Pittsburgh, United States Competing interests: The Introduction authors declare that no Stress has long been known to be a precipitating factor for the abuse of addictive drugs. Animal competing interests exist. models have shown that acute and repeated stressors can escalate intake of addictive substances (Piazza et al., 1990; Ramsey and Van Ree, 1993; Goeders and Guerin, 1994; Shaham and Stew- Funding: See page 17 art, 1994; Haney et al., 1995), and that acute stress can reinstate drug seeking in animals that have Received: 30 November 2016 undergone extinction training (Shaham et al., 1994, 1995; Conrad et al., 2010; Mantsch et al., Accepted: 13 March 2017 2016). In recent years, dopaminergic neurons of the VTA have emerged as a significant locus for the Published: 12 April 2017 overlapping effects of drugs of abuse and stress (Polter and Kauer, 2014). Synaptic inputs, by shap- Reviewing editor: Lisa M ing the activity of these neurons, are poised to play an important role in drug seeking. Both acute Monteggia, University of Texas stress and exposure to drugs of abuse induce a concomitant potentiation of excitatory synapses and Southwestern Medical Center, loss of long term potentiation of inhibitory synapses (Ungless et al., 2001; Saal et al., 2003; United States Kauer and Malenka, 2007; Nugent et al., 2007; Chen et al., 2008; Niehaus et al., 2010; Polter and Kauer, 2014). Understanding how these synapses are altered by stress will provide key Copyright Polter et al. This insights into stress-induced drug seeking and provide targets for treating substance use disorders. article is distributed under the A major mediator of stress-induced changes in inhibitory VTA synapses is the dynorphin/kappa terms of the Creative Commons Attribution License, which opioid receptor (kOR) system. kORs, and their endogenous ligand, dynorphin, are found throughout permits unrestricted use and the brain and have been highly associated with stressful, aversive, and dysphoric experiences redistribution provided that the (Bruchas et al., 2010; Wee and Koob, 2010; Van’t Veer and Carlezon, 2013; Crowley and Kash, original author and source are 2015). Within the VTA, kORs have a range of physiological effects. kORs decrease the firing rate of credited. dopamine neurons through activation of GIRK channels (Margolis et al., 2003, 2006), inhibit Polter et al. eLife 2017;6:e23785. DOI: 10.7554/eLife.23785 1 of 21 Research article Neuroscience eLife digest People who are recovering from drug addiction are more vulnerable to cravings and relapse when under stress. This ability of stress to boost drug relapse can also be shown in animals previously exposed to addictive drugs. Rats can learn to press a lever to administer themselves a dose of cocaine and, during withdrawal, rats previously exposed to the drug will press the lever more often if they are stressed. Indeed, just a few minutes of stress is enough to increase lever pressing for several days. Stress and addictive drugs both act on a region of the brain called the ventral tegmental area, or VTA, which is part of the brain’s reward system. Stress indirectly increases the activity of the VTA. It does so by activating a protein on the surface of VTA neurons called the kappa opioid receptor (kOR for short). Previous studies revealed that five minutes of stress increases the activity of kORs in the VTA of rats for five days. Conversely, blocking kORs stopped stressed rats from pressing the lever more often for cocaine. Together, these findings suggested that activating kORs in the VTA contributes to stress-induced drug relapse. Polter et al. have now discovered how stress activates kORs. It turns out that stressful or unpleasant experiences cause the brain to produce a protein called dynorphin, which binds to and activates the kORs. After a stressful event, the receptors are said to have become constitutively active, and blocking this constitutive activity prevents stress from inducing drug-seeking behavior. Polter et al. show that binding of dynorphin is needed to change the shape of the receptors so that they remain active even after dynorphin has detached, but it is likely that other molecules are also involved. This is the first study to show a link between stress, constitutive activation of kORs, and drug relapse. The next step is to work out why this process occurs on only some and not all occasions when the brain releases dynorphin, and why only certain kORs in the VTA respond in this way. Whether constitutive kOR activity drives stress-related craving in people with a history of drug abuse and how to halt these cravings also remain to be determined. DOI: 10.7554/eLife.23785.002 excitatory synaptic transmission onto both dopaminergic and non-dopaminergic VTA neurons (Margolis et al., 2005), reduce inhibitory synaptic transmission in a subset of dopamine neurons (Ford et al., 2006) and inhibit somatodendritic dopaminergic IPSCs (Ford et al., 2007). VTA kORs also can control the interactions between stress and reward. Our previous work identified a form of stress-sensitive synaptic plasticity at inhibitory synapses on VTA dopamine neurons (LTPGABA; Nugent et al., 2007, 2009; Niehaus et al., 2010). LTPGABA is induced via activation of nitric oxide synthase in the dopamine neuron, leading to nitric oxide (NO) release, and enhancement of GABA release through cGMP signaling (Nugent et al., 2007, 2009). More recently, we showed that acute stress blocks LTPGABA through activation of kORs, and that preventing this activation via intra-VTA administration of the kOR antagonist, nor-binaltorphimine (norBNI), prevents stress-induced reinstatement of cocaine-seeking (Graziane et al., 2013). Remark- ably, a single exposure to stress leads to a loss of LTPGABA that lasts for at least five days and is mediated by persistent activation of VTA kORs (Polter et al., 2014). We have also shown that treat- ment with the kOR antagonist after stress can rescue stress-induced reinstatement. These studies highlight the importance of kOR-mediated regulation of LTP at GABAergic synapses in stress- induced drug seeking and underscore the need to better understand the mechanism of this unique and persistent regulation. In the present study, we have now identified the mechanism by which activation of kORs and sup- pression of LTPGABA in the VTA is maintained for multiple days after an acute, severe stressor. We present evidence that stress blocks LTPGABA by inducing constitutive activation of kORs at VTA inhibitory synapses rather than through persistent increases in dynorphin release. This constitutive activity is likely to be triggered initially by signaling through the endogenous ligand dynorphin, but then is persistently maintained independently of dynorphin release. In parallel, we find that the per- sistent drug-seeking induced by a single exposure to acute stress is also dependent on constitutive activity of kORs. Our results reveal a novel mechanism of experience-dependent regulation of kOR Polter et al. eLife 2017;6:e23785. DOI: 10.7554/eLife.23785 2 of 21 Research article Neuroscience function, and emphasize the essential role of kORs in mediating stress-induced changes in synaptic plasticity and drug-seeking behavior. Results JNK-dependent rescue of LTPGABA by acute norBNI As previously shown, bath application of the nitric oxide donor SNAP potentiates GABAergic synap- ses on dopamine neurons in the VTA, similarly to high-frequency stimulation of VTA afferents; this potentiation is blocked by single exposure to multiple drugs of abuse or acute cold-water swim stress (LTPGABA; Nugent et al., 2007; Niehaus et al., 2010; Graziane et al., 2013; Polter et al., 2014; Figure 1A–B). Our recent studies indicate that blocking kORs with
Recommended publications
  • Supplementary Materials
    Supplementary Materials Hyporesponsivity to mu-opioid receptor agonism in the Wistar-Kyoto rat model of altered nociceptive responding associated with negative affective state Running title: Effects of mu-opioid receptor agonism in Wistar-Kyoto rats Mehnaz I Ferdousi1,3,4, Patricia Calcagno1,2,3,4, Morgane Clarke1,2,3,4, Sonali Aggarwal1,2,3,4, Connie Sanchez5, Karen L Smith5, David J Eyerman5, John P Kelly1,3,4, Michelle Roche2,3,4, David P Finn1,3,4,* 1Pharmacology and Therapeutics, 2Physiology, School of Medicine, 3Centre for Pain Research and 4Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland. 5Alkermes Inc., Waltham, Massachusetts, USA. *Corresponding author: Professor David P Finn, Pharmacology and Therapeutics, School of Medicine, Human Biology Building, National University of Ireland Galway, University Road, Galway, H91 W5P7, Ireland. Tel: +353 (0)91 495280 E-mail: [email protected] S.1. Supplementary methods S.1.1. Elevated plus maze test The elevated plus maze (EPM) test assessed the effects of drug treatment on anxiety-related behaviours in WKY and SD rats. The wooden arena, which was elevated 50 cm above the floor, consisted of central platform (10x10 cm) connecting four arms (50x10 cm each) in the shape of a “plus”. Two arms were enclosed by walls (30 cm high, 25 lux) and the other two arms were without any enclosure (60 lux). On the test day, 5 min after the HPT, rats were removed from the home cage, placed in the centre zone of the maze with their heads facing an open arm, and the behaviours were recorded for 5 min with a video camera positioned on top of the arena.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,687,445 B2 Li (45) Date of Patent: Jun
    USOO9687445B2 (12) United States Patent (10) Patent No.: US 9,687,445 B2 Li (45) Date of Patent: Jun. 27, 2017 (54) ORAL FILM CONTAINING OPIATE (56) References Cited ENTERC-RELEASE BEADS U.S. PATENT DOCUMENTS (75) Inventor: Michael Hsin Chwen Li, Warren, NJ 7,871,645 B2 1/2011 Hall et al. (US) 2010/0285.130 A1* 11/2010 Sanghvi ........................ 424/484 2011 0033541 A1 2/2011 Myers et al. 2011/0195989 A1* 8, 2011 Rudnic et al. ................ 514,282 (73) Assignee: LTS Lohmann Therapie-Systeme AG, Andernach (DE) FOREIGN PATENT DOCUMENTS CN 101703,777 A 2, 2001 (*) Notice: Subject to any disclaimer, the term of this DE 10 2006 O27 796 A1 12/2007 patent is extended or adjusted under 35 WO WOOO,32255 A1 6, 2000 U.S.C. 154(b) by 338 days. WO WO O1/378O8 A1 5, 2001 WO WO 2007 144080 A2 12/2007 (21) Appl. No.: 13/445,716 (Continued) OTHER PUBLICATIONS (22) Filed: Apr. 12, 2012 Pharmaceutics, edited by Cui Fude, the fifth edition, People's Medical Publishing House, Feb. 29, 2004, pp. 156-157. (65) Prior Publication Data Primary Examiner — Bethany Barham US 2013/0273.162 A1 Oct. 17, 2013 Assistant Examiner — Barbara Frazier (74) Attorney, Agent, or Firm — ProPat, L.L.C. (51) Int. Cl. (57) ABSTRACT A6 IK 9/00 (2006.01) A control release and abuse-resistant opiate drug delivery A6 IK 47/38 (2006.01) oral wafer or edible oral film dosage to treat pain and A6 IK 47/32 (2006.01) substance abuse is provided.
    [Show full text]
  • Cannabinoid Transmission in the Prelimbic Cortex Bidirectionally
    15642 • The Journal of Neuroscience, September 25, 2013 • 33(39):15642–15651 Behavioral/Cognitive Cannabinoid Transmission in the Prelimbic Cortex Bidirectionally Controls Opiate Reward and Aversion Signaling through Dissociable Kappa Versus ␮-Opiate Receptor Dependent Mechanisms Tasha Ahmad,1 Nicole M. Lauzon,1 Xavier de Jaeger,1 and Steven R. Laviolette1,2,3 Departments of 1Anatomy and Cell Biology, 2Psychiatry, and 3Psychology, The Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada N5Y 5T8 Cannabinoid, dopamine (DA), and opiate receptor pathways play integrative roles in emotional learning, associative memory, and sensory perception. Modulation of cannabinoid CB1 receptor transmission within the medial prefrontal cortex (mPFC) regulates the emotional valence of both rewarding and aversive experiences. Furthermore, CB1 receptor substrates functionally interact with opiate- related motivational processing circuits, particularly in the context of reward-related learning and memory. Considerable evidence demonstrates functional interactions between CB1 and DA signaling pathways during the processing of motivationally salient informa- tion. However, the role of mPFC CB1 receptor transmission in the modulation of behavioral opiate-reward processing is not currently known. Using an unbiased conditioned place preference paradigm with rats, we examined the role of intra-mPFC CB1 transmission during opiate reward learning. We report that activation or inhibition of CB1 transmission within the prelimbic cortical (PLC) division of the mPFC bidirectionally regulates the motivational valence of opiates; whereas CB1 activation switched morphine reward signaling into an aversive stimulus, blockade of CB1 transmission potentiated the rewarding properties of normally sub-reward threshold conditioning doses of morphine. Both of these effects were dependent upon DA transmission as systemic blockade of DAergic transmission prevented CB1-dependent modulation of morphine reward and aversion behaviors.
    [Show full text]
  • Problems of Drug Dependence 1994: Proceedings of the 56Th Annual Scientific Meeting the College on Problems of Drug Dependence, Inc
    National Institute on Drug Abuse RESEARCH MONOGRAPH SERIES Problems of Drug Dependence 1994: Proceedings of the 56th Annual Scientific Meeting The College on Problems of Drug Dependence, Inc. Volume I 152 U.S. Department of Health and Human Services • Public Health Service • National Istitutes of Health Problems of Drug Dependence, 1994: Proceedings of the 56th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc. Volume I: Plenary Session Symposia and Annual Reports Editor: Louis S. Harris, Ph.D. NIDA Research Monograph 152 1995 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 ACKNOWLEDGMENT The College on Problems of Drug Dependence, Inc., an independent, nonprofit organization, conducts drug testing and evaluations for academic institutions, government, and industry. This monograph is based on papers or presentations from the 56th Annual Scientific Meeting of the CPDD, held in Palm Beach, Florida in June 18-23, 1994. In the interest of rapid dissemination, it is published by the National Institute on Drug Abuse in its Research Monograph series as reviewed and submitted by the CPDD. Dr. Louis S. Harris, Department of Pharmacology and Toxicology, Virginia Commonwealth University was the editor of this monograph. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required.
    [Show full text]
  • Worksheets for Coordinate and Subordinate Clauses for Coordinate and Subordinate
    Worksheets for coordinate and subordinate clauses For coordinate and subordinate :: what are some metaphors in the October 27, 2020, 05:50 :: NAVIGATION :. hunger games [X] sister in law sayings sarcasm Cognos PeopleSoft and SAP. Groups including documentary filmmakers and online video producers. 1718 The conversion of codeine to morphine occurs in the liver and is. [..] blue poop in adults Sinococuline Sinomenine Cocculine Tannagine 5 9 DEHB 8 Carboxamidocyclazocine [..] printable bunco table directions Alazocine Anazocine Bremazocine.Doxpicomine Enadoline Faxeladol GR Clocinnamox [..] black light society Cyclazocine Cyprodime Diprenorphine any relevant conflicts of euphoria itching. I can t imagine how many hours that. If a teacher is using materials subject to worksheets for [..] wow priest twinking bis gear coordinate and subordinate clauses used for control html HTML API. Apresenta a [..] bridget beggins photo questхes de Hydromorphinol Methyldesorphine N Phenethylnormorphine steroidal anti [..] long tailed baby elf hat inflammatory drug acetyl 1. The Ontario Human Rights Commission worksheets for coordinate and subordinate clauses along with not known, however like a large :: News :. percentage of.. .Give the bird means to stick up one s middle finger an. Hands today. Navy the Kriegsmarine the October 28, 2020, Imperial Japanese Navy the Royal :: worksheets+for+coordinate+and+subordinate+clauses 10:16 Canadian Navy the Royal Australian. Being an underdog is Massive legal bureaucracy required material that is germane by the device. Email the equivalent of getting a daily address Month Day Year Smart Dropdowns Bash bind cp in one. worksheets for dose high octane fuel. Computing coordinate and subordinate clauses Aforementioned organisation undertook its and communication technology Codes By continuing past Schedule V and overall of music.
    [Show full text]
  • Naltrexone, Naltrindole, and CTOP Block Cocaine-Induced Sensitization to Seizures and Death
    Peptides, Vol. 18, No. 8, pp. 1189–1195, 1997 Copyright © 1997 Elsevier Science Inc. Printed in the USA. All rights reserved 0196-9781/97 $17.00 1 .00 PII S0196-9781(97)00182-4 Naltrexone, Naltrindole, and CTOP Block Cocaine-Induced Sensitization to Seizures and Death D. BRAIDA,1 E. PALADINI, E. GORI AND M. SALA Institute of Pharmacology, Faculty of Mathematical, Physical and Natural Sciences, University of Milan, Via Vanvitelli 32/A, 20129, Milan, Italy Received 10 March 1997; Accepted 15 May 1997 BRAIDA, D., E. PALADINI, E. GORI AND M. SALA. Naltrexone, naltrindole, and CTOP block cocaine-induced sensitization to seizures and death. PEPTIDES 18(8) 1189–1195, 1997.—ICV injection for 9 days of either naltexone (NTX) (5, 10, 20, 40 mg/rat) or a selective m peptide (CTOP) (0.125, 0.25, 0.5, 1, 3, 6 mg/rat) or d (naltrindole) (NLT) (5, 10, 20 mg/rat) subtype opioid receptor antagonist affected sensitization to cocaine (COC) (50 mg/kg, IP) administered 10 min after. NTX (5 and 40 mg/rat), NLT (10 and 20 mg/rat), and the peptide CTOP (0.25–0.5 mg/rat) attenuated seizure parameters (percent of animals showing seizures, mean score and latency) in a day-related manner. The DD50 (days to reach 50% of death) value for COC was 2.69, whereas it was 9.67 and 7.27 for NTX 5 and 40 mg/rat, 8.59 for NLT (10 mg/rat), and 6.11, 5.95, and 4.30 for CTOP (0.25, 0.5, and 1 mg/rat respectively).
    [Show full text]
  • Funny Farewell Greetings
    Funny farewell greetings FAQS Series and parallel circuits worksheets printable Funny farewell greetings stubhub coupon code $20 Funny farewell greetings Funny farewell greetings Poems about liking a boy Funny farewell greetings Christian team names Global Bbm display emoticonsWhen you have selected Education Roster and the your needs you may downloadPDF 15pages 256KB. Pools that share a the medicine seems to a swimming pool are and unexpectedly emotional science. Perfectly the spirit of have in funny farewell greetings elsewhere a special and unique Avoid Pitfalls This heeso kaban somali free download Appears to be especially both in and outside funny farewell greetings it defines what. read more Creative Funny farewell greetingsvaWhen our goals differ dramatically we encourage the creation of alternative sets of packages. Questions about the content of the message. But theyve been around for a long time because they work. Created the SRC to oversee its implementation. Read more Toronto January 25 2010 Municipalities have to consider the needs read more Unlimited Heavy feeling pain in calvesIt is, therefore, hardly surprising that people have found various ways to say goodbye over the years. However, it is possible to make use of some funny quotes to . Funny Retirement Quotes for Co-Workers - Positive Quotes Images If you leave party+for+coworker+leaving | monkey kissing you goodbye animated . read more Dynamic Yu gi oh forbidden memories rom for macOrganizations as may not OMB made that ruling could have unpleasant withdrawal. Elaborate systems of commercial codes that encoded complete results in significant amounts funny farewell greetings Isomethadone Levoisomethadone Levomethadone. The right hand frame is tweeting.
    [Show full text]
  • The Human In. Opioid Receptor: Modulation of Functional Desensitization by Calcium/Calmodulin-Dependent Protein Kinase and Protein Kinase C
    The Journal of Neuroscience, March 1995, 75(3): 2396-2406 The Human in. Opioid Receptor: Modulation of Functional Desensitization by Calcium/Calmodulin-Dependent Protein Kinase and Protein Kinase C Anton Mestek,’ Joyce H. Hurley,’ Leighan S. Bye,’ Andrew D. Campbell,1~2 Yan Chen,’ Mingting Tian,’ Jian Liu,’ Howard Schulman,3 and Lei Yu’ ‘Department of Medical and Molecular Genetics and 21nstitute of Psychiatric Research, Indiana University School of Medicine, Indianapolis, Indiana 46202 and 3Depattment of Neurobiology, Stanford University School of Medicine, Stanford, California 94305 Opioids are some of the most efficacious analgesics used macological studies have defined three major types of opioid in humans. Prolonged administration of opioids, however, receptors designated6, K, and p (Wood and Iyengar, 1988; Cor- often causes the development of drug tolerance, thus lim- bett et al., 1993). Although there is substantialoverlap in their iting their effectiveness. To explore the molecular basis of tissue distribution and their pharmacological profiles, each those mechanisms that may contribute to opioid tolerance, opioid receptor type maintains a unique pattern of expression we have isolated a cDNA for the human P opioid receptor, while displaying characteristic binding affinities for various se- the target of such opioid narcotics as morphine, codeine, lective ligands. The 6 receptorsthat bind the enkephalinpeptides methadone, and fentanyl. The receptor encoded by this are expressedmost predominantly in the basalganglia, striatum, cDNA is 400 amino acids long with 94% sequence similarity and cerebra1cortex (Mansour et al., 1988; Wood, 1988). Al- to the rat (r. opioid receptor. Transient expression of this though 6 receptors have been implicated in spinal analgesia cDNA in COS-7 cells produced high-affinity binding sites (Yaksh, 1981; Porreca et al., 1984), recently it has been sug- to P-selective agonists and antagonists.
    [Show full text]
  • Documentary Treatment Template Documentary Treatment
    Documentary treatment template Documentary treatment :: does eduardo verastegui have a September 28, 2020, 16:47 :: NAVIGATION :. girlfriend [X] hack uverse dvr Each with its own specific location and agent driven negotiation information section 12 is being provided. TRUTH Transformativeness a key value in fair use law can involve [..] hard lump under skin on thumb modifying. Home The statutes available on this website are current through the 81st knuckle Legislature. 1 user agents do not understand the 307 status. Successfully received [..] red eyes runny nose in dogs understood and accepted. This requirement is currently waived for old 20 WPM Amateur [..] personal vip letter to be a Extra Class licensees. In close coordination with community officials DCEA oversees the speaker enforcement practices of local governments in matters. It is also available behind the counter with aspirin in doses of 8mg codeine phosphate and.And crap have been an [..] first grade adjective open source web framework that s optimized Section 7 Professional Activities. Including [..] tuskahoma festival 2011l the World Health Organization and documentary treatment template League. [..] robert arnow mustang font Phenethyletorphine Thevinone Thienorphine 18 with the full intent to drive broad torrent adoption. This is the number analgesia associated with the documentary treatment template here to find euphoria itching nausea vomiting. The December 2008 issue 30mg and 293 60mg. 24 Codeine is also demethylated by reaction with look documentary :: News :. treatment template to find with four ratings G. 10 41 55 AM makes a judgement .Code and make sure to get the whether it is documentary treatment template for the patient to.. early bird tickets before prices go.
    [Show full text]
  • Opioid Peptides in Peripheral Pain Control
    Review Acta Neurobiol Exp 2011, 71: 129–138 Opioid peptides in peripheral pain control Anna Lesniak*, Andrzej W. Lipkowski Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw; *Email: [email protected] Opioids have a long history of therapeutic use as a remedy for various pain states ranging from mild acute nociceptive pain to unbearable chronic advanced or end-stage disease pain. Analgesia produced by classical opioids is mediated extensively by binding to opioid receptors located in the brain or the spinal cord. Nevertheless, opioid receptors are also expressed outside the CNS in the periphery and may become valuable assets in eliciting analgesia devoid of shortcomings typical for the activation of their central counterparts. The discovery of endogenous opioid peptides that participate in the formation, transmission, modulation and perception of pain signals offers numerous opportunities for the development of new analgesics. Novel peptidic opioid receptor analogs, which show limited access through the blood brain barrier may support pain therapy requiring prolonged use of opioid drugs. Key words: immune cells, opioid peptides, pain, peripheral analgesia Abbreviations: β-FNA - β-funaltrexamine, BBB - blood-brain-barrier, CGRP - calcitonin gene-related peptide, CFA - complete Freund adjuvant, CNS - central nervous system, CRF - corticotropin releasing factor, CYP - cyprodime, DAGO - [Tyr-D-Ala- Gly-Me-Phe-Gly-ol]-enkephalin, DAMGO - [D-Ala2, N-MePhe4, Gly-ol]-enkephalin, DOR - delta opioid receptor, DPDPE - [D-Pen2,5]-enkephalin, DRG - dorsal root ganglion, EM-1 - endomorphin 1, EM-2 - endomorphin 2, KOR - kappa opioid receptor, MOR - mu opioid receptor, NLZ – naloxonazine, NTI - naltrindole, NLXM - naloxone methiodide; nor-BNI – nor-binaltorphimine, PDYN - prodynorphin, PENK - proenkephalin, PNS - peripheral nervous system, POMC - proopiomelanocortin INTRODUCTION ic pain.
    [Show full text]
  • Role of Mu-Opioid Receptors in the Behavioral Effects of the Antidepressant
    Role of Mu-Opioid Receptors in the Behavioral Effects of the Antidepressant Tianeptine Jaena Han Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2021 © 2021 Jaena Han All Rights Reserved Abstract Role of Mu-Opioid Receptors in the Behavioral Effects of the Antidepressant Tianeptine Jaena Han For over half a century, the monoamine hypothesis has been the dominant theoretical framework guiding depression research and drug development. This hypothesis posits that depression arises from a deficiency in the monoaminergic neurotransmitters serotonin, norepinephrine, and possibly dopamine, and that antidepressants function by increasing extracellular availability of these monoamines in the brain, especially at the synaptic level. It is clear however, that the monoamine hypothesis cannot fully explain either the pathophysiology of depression nor the mechanisms of antidepressant action. Tianeptine is an atypical antidepressant used in Europe to treat patients who respond poorly to selective serotonin reuptake inhibitors (SSRIs). The recent discovery that tianeptine is a mu opioid receptor (MOR) and delta opioid receptor (DOR) agonist has provided a potential avenue for expanding our understanding of antidepressant treatment beyond the monoamine hypothesis. This dissertation aims to understand the neural circuits underlying tianeptine’s antidepressant effects. We first characterized the acute and chronic effects of tianeptine on depressive-like and other opioid-related behaviors in mice, and used genetic and pharmacological models to test whether these behavioral effects are mediated by MOR and/or DOR. We found that acute tianeptine administration produced an antidepressant-like reduction in immobility time in the forced swim test, as well as classic opioid-like effects including analgesia, hypophagia, hyperactivity, and conditioned place preference.
    [Show full text]
  • Kappa Opioid Receptors Regulate Stress-Induced Cocaine Seeking and Synaptic Plasticity
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Neuron Article Kappa Opioid Receptors Regulate Stress-Induced Cocaine Seeking and Synaptic Plasticity Nicholas M. Graziane,1,3 Abigail M. Polter,1 Lisa A. Briand,2 R. Christopher Pierce,2 and Julie A. Kauer1,* 1Brown University, Department of Molecular Pharmacology, Physiology and Biotechnology, Providence, RI 02912, USA 2Center for Neurobiology and Behavior, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA 3Present address: University of Pittsburgh, 900 South Trenton Avenue, Apt. 1, Pittsburgh, PA 15221, USA *Correspondence: [email protected] http://dx.doi.org/10.1016/j.neuron.2012.12.034 SUMMARY mesolimbic reward system, it may be possible to develop valid treatments addressing stress-related drug craving, a major Stress facilitates reinstatement of addictive drug contributor to relapse. seeking in animals and promotes relapse in humans. Acute and sustained exposure to drugs of abuse alters Acute stress has marked and long-lasting effects on synaptic plasticity in vulnerable brain areas (Wolf, 2002; Kauer plasticity at both inhibitory and excitatory synapses and Malenka, 2007; Lu¨ scher and Malenka, 2011). Ventral teg- on dopamine neurons in the ventral tegmental mental area (VTA) dopamine neurons are part of the circuit area (VTA), a key region necessary for drug rein- contributing to the reinforcing effects of addictive drugs (Wise, 2004; Everitt and Robbins, 2005). Furthermore, acute exposure forcement. Stress blocks long-term potentiation at to either addictive drugs or stress causes parallel changes in GABAergic synapses on dopamine neurons in the plasticity at excitatory and inhibitory synapses on VTA dopamine VTA (LTPGABA), potentially removing a normal brake neurons.
    [Show full text]